Author Archives: admin


Daily Edition for Wednesday, November 4, 2020 – California Healthline

Latest From California Healthline:

A Biden Win and Republican Senate Might Lead to Gridlock on Health Issues

If Democrat Joe Biden is successful in his bid for the presidency but the Senate remains in GOP control, Democrats plans for major changes in health care may be curbed. The federal role in those policies is at stake as is Californias ambitious health care agenda. (Julie Rovner, 11/3)

Los Angeles Times: Prop. 23, Which Would Have Imposed New Regulations On Dialysis Industry, Fails A $100-million effort to impose new regulations on the dialysis industry was defeated Tuesday. Proposition 23 would have required dialysis clinics to employ at least one doctor who would be on site whenever patients are receiving treatment. Supporters of the measure, including the Service Employees International Union-United Healthcare Workers West, said dialysis clinics were putting profits over patient care by not having a doctor available in the event of complications or an emergency. (Gutierrez, 11/3)

San Francisco Chronicle: Prop. 23: California Measure To Stiffen Regulations At Dialysis Clinics Fails California voters have rejected Proposition 23, a ballot initiative that would have created new safety regulations for kidney dialysis clinics that serve 80,000 patients. The initiative sought to require that clinics always have a doctor on site during treatments, which patients with kidney failure must receive routinely to stay alive. Prop. 23 was behind by a wide margin in unofficial returns, with a simple majority needed for passage. (Gardiner, 11/3)

Los Angeles Times: Prop. 14 Leading In Early Results On Stem Cell Bond A ballot measure to authorize $5.5 billion in new funding for stem cell research was leading in early returns Tuesday. Proposition 14 asked voters to approve an infusion of cash for the California Institute for Regenerative Medicine, known as CIRM, for stem cell studies and trials. California voters created CIRM in 2004 after approving a bond measure that year for $3 billion. CIRM used that bond money for research grants, new laboratories and training programs, but unallocated funds ran out last year, prompting supporters of the agency to return to taxpayers for additional money. (Gutierrez, 11/3)

Los Angeles Times: A Close Race On Proposition 15 To Loosen Californias Business Property Tax Rules The fate of Proposition 15, an effort to remove high-value business properties from the low-tax protections enacted by California voters more than four decades ago, was unclear in early election returns Tuesday, after an expensive and fierce campaign over how much to spend on government services and the economic effects of raising taxes. The ballot measure was opposed by a razor-thin majority with more than 9.5 million ballots counted, a shortfall that was far from certain with millions of votes left to count. (Myers, 11/3)

Los Angeles Times: California Voters Approve Prop. 22, Allowing Uber And Lyft Drivers To Remain Independent Contractors Californians sided with the $200-million Proposition 22 campaign led by Uber and Lyft, voting to pass the measure and grant ride-hail and delivery companies an exemption from California employment law to continue treating workers as independent contractors. The fight was one of the most closely watched ballot measure contests in the country and the costliest in state history. A win for the app-based companies has the potential to create a new campaign paradigm, with companies sidestepping government and spending large sums of money to sway voters with traditional advertisements and more unconventional direct marketing to customers. The measures passage also deals a blow to Californias powerful labor unions, underdogs in the race with far fewer financial resources than their foes. (Luna, 11/3)

Los Angeles Times: Californians Once Again Reject Bid To Expand Rent Control In The State The failure of Proposition 21 means that, once again, landlord groups have convinced voters that stricter limits on rent hikes are not a solution to Californias housing affordability problems. A statewide ban on most new forms of rent control will remain in effect. Yet again, California voters clearly understood the negative impacts Prop. 21 would have had on the availability of affordable housing in our state by clearly rejecting this radical ballot measure, said Tom Bannon, chief executive of the California Apartment Assn., in a statement. It is now time to move from ballot-box battles and enact policies through the Legislature that allow the state to build more affordable housing that will once again make California an affordable place to live for our families. (Dillon, 11/3)

Santa Rosa Press Democrat: Measure O: Sonoma County Voters Backing Tax Measure For Mental Health, Homeless Services Voters early Wednesday were supporting a ballot measure that would raise sales taxes in Sonoma County to boost local spending on mental health and homelessness services by $25 million annually. (Silvy, 11/4)

AP VoteCast: California Voters Sour On State Of Nation Voters in California made their pick for president while holding negative views about the countrys direction, according to an expansive AP survey of the American electorate. The race between President Donald Trump and Democratic rival Joe Biden concluded Tuesday as the nation remains in the throes of a global public health crisis and mired in the economic downturn it brought on. AP VoteCast found that almost three-fourths of California voters said the U.S. is headed in the wrong direction and about a quarter of voters said it is on the right track. (Keller, 11/4)

AP: California Chooses Biden, State GOP Hoping For US House Wins California delivered a strong rebuke to Donald Trumps presidency on Tuesday as Democrat Joe Biden ran up the score in the liberal state with a victory of 4 million votes in an election upended by the coronavirus pandemic. Bidens supersized victory didnt derail the state GOPs hopes of clawing back some of the seven U.S. House seats he party lost two years ago. Republican candidates had narrow leads over two Democratic incumbents in Orange County while another GOP incumbent clung to a small lead in the Central Valley. (Beam, 11/4)

AP: Some California Legislative Incumbents Fighting To Survive California Democrats were hoping to expand their supermajorities in the state Legislature as votes were tallied Tuesday. Several Republican incumbents in the 80-member Assembly and 40-member Senate were in danger of defeat. And with Californias top-two balloting, voters in some cases set up contests within the same political party by advancing the two highest vote-getters from the March primary election. Several in Orange County, the greater Los Angeles area and in the San Francisco Bay Area face challengers and have drawn high spending from interest groups. (Thompson, 11/4)

Bay Area News Group: Californias COVID-19 Cases Continue To Rise COVID-19 cases are continuing to climb, furthering a pattern thats trending in the wrong direction following two months where the numbers were stagnant. The seven-day average for the state increased for the second straight day, from about 4,162 cases per day through Sunday to 4,306 on Monday. It had decreased for four straight days following an eight-day stretch in which the number went up each day. The seven-day average no longer reflects the artificial increase of 6,300 backlogged tests in Los Angeles that were added in late October. (Hurd, 11/3)

Modesto Bee: Announcement Delayed For States Coronavirus Tier System. Stanislaus Cutting It Close Citing Tuesdays national election, California health officials postponed an update on coronavirus tier assignments until Wednesday. The weekly updates assigning counties to different levels of COVID-19 restrictions are usually released on Tuesdays. Dr. Julie Vaishampayan, health officer for Stanislaus County, told the Board of Supervisors the countys daily case rate was right at the key metric of 7 per 100,000 population. The county needs to stay below that limit to meet criteria for the red tier, which places lighter restrictions on restaurants, retail shopping areas, fitness centers and worship services. (Carlson, 11/3)

Sacramento Bee: 11 Dead Of COVID-19 At Woodland Skilled Nursing Home A skilled nursing facility in Northern California has been ravaged by two separate coronavirus outbreaks, with at least 11 residents dead and dozens still sick. Nearly 100 combined residents and staff at Alderson Convalescent Hospital in Woodland have tested positive for COVID-19 in two waves of infection occurring three months apart, according to Yolo County health officials. In early July, 17 residents and 10 staff members at the 140-bed facility contracted the respiratory disease, and three of the residents died, Yolo officials said. (McGough, 11/3)

Fresno Bee: If Fresno-Area COVID-19 Cases Spike Again, These Local Schools Could Still Reopen Classrooms Fresno County has remained in the red-tier according to Californias color-coded Blueprint for a Safer Economy, meaning schools can start to re-open. Many schools continue to apply for re-opening waivers as a safety measure if the area falls back into the most restrictive purple tier. A 14-day rolling average shows the county continues to report an average of at least 100 new coronavirus cases per day. Health professionals are also concerned with rising COVID-19 cases as winter approaches in lockstep with cold and flu season. (Dieppa, 11/3)

The Bakersfield Californian: Housing Project For Homeless Women, Children Slated For Panorama Bluffs Draws Opposition From Neighbors Plans to convert a single-family home overlooking the bluffs of northeast Bakersfield into a transitional residence for homeless women and children has drawn opposition from neighbors but received an endorsement from the city's planning department last week to proceed.(Shepard, 11/2)

The Bakersfield Californian: Please Don't Burn Wood At Home, Air Officials Beseech Residents In 'Worst Wildfire Season' "To protect the health of their families and their neighbors, we encourage residents to not burn wood this winter and instead choose to upgrade to natural gas devices through our grant program," he said. (Mayer, 11/3)

San Francisco Chronicle: One Bay Area Hospital Is Prepping For A Rise In Heart Attacks Caused By Election Stress Regional Medical Center in San Jose put extra staff on call Tuesday to handle what doctors believe could be a 15% increase in patients experiencing an array of cardiac issues caused by the stress of election day. These kind of stresses cause a well-documented increase in cardiovascular events, said Dr. Paul Silka, director of the emergency room at Regional Medical Center of San Jose. The 45-bed emergency room usually sees 185 patients a day. Because of the election, Silka expects that to go up to 210 patients or so. (Rubenstein, 11/3)

Becker's: California Health System To Lay Off 31 Workers NorthBay Healthcarewill lay off31 full-time workers as part of its pandemic recovery plan, the system said Nov. 2.The Fairfield, Calif.-based nonprofit health system said it needs to adjust operations to fit a new healthcare reality brought by the COVID-19 pandemic.(11/3)

Go here to read the rest:
Daily Edition for Wednesday, November 4, 2020 - California Healthline

‘We’re truly blood brothers’ – Stanford coach David Shaw and his recent fight to save his brother, Eric – ESPN

David Shaw walks into the hospital room and takes a seat next to the bed. He does this nearly every day, right around lunchtime.

He looks at his younger brother, Eric, tubes snaking across his arms, machines beeping and whirring. Eric does not look like Eric anymore, his skin darkened, scars deepened, features altered. They both know this but never mention it.

They talk about movies, or random memories from their childhood when they were often inseparable, riding bikes, playing video games and challenging each other to one-on-one basketball. They avoid talking about why David comes as often as he does to visit, though they know the reason.

Eric is dying, a rare, aggressive skin cancer rampaging through his body with such ferocity that his doctors are nearly out of options. Radiation failed. Chemotherapy failed. Two bone marrow transplants failed.

As Stanford's head football coach, David Shaw is relied on to always know what to say, how to say it and when to say it; but he cannot find the words now that he and his brother are staring down what seems to be an inevitable fate.

"What do you say, where you think you've pulled at the last thread and there are no more threads?" David said. "All I could tell him was that I loved him and that I was there for him. The rest of it was really just ... I thought it was only a matter of time before he passed away."

Two years later, what happened between David and Eric remains real, present and raw -- changing their entire relationship, redefining what it means to be a brother. The words are still difficult to say, so they tip-toe around the crushing physical and mental toll Eric's cancer took on them.

David and Eric are sure to think about it all this weekend, when Stanford opens its season at Oregon on Saturday. Because the last time the Cardinal visited Eugene, neither one knew whether Eric would live or die.

After Stanford came from behind to win that game 38-31 in overtime, David delivered a message at the end of his postgame television interview, looking at the camera and saying, "To my brother Eric: I love you." He tapped the lime green pin on his black Stanford sweatshirt before he left the screen.

When Shaw became head coach at Stanford in 2011, it was the culmination of a family journey. His father was a longtime coach there; David played receiver for the Cardinal and eventually returned as an assistant under Jim Harbaugh. The entire Shaw family -- parents Willie and Gay, along with David, Eric and their sister, Tawnya -- all call the Bay Area home.

To this day, David says the day he was introduced as coach was "one of the better days in all our lives."

Yet something started to happen to Eric that no one could quite figure out. That same year, Eric found strange looking spots on his torso. His wife, Crystal, noticed the first one under his arm. Maybe it was eczema, they thought. Then the spots started to spread. He went to the doctor. They prescribed an ointment, but the spots kept popping up, until they covered his entire body. Eventually, tumors started to grow. It looked as if someone had pushed marbles under his skin. Doctors remained confounded. Eric itched uncontrollably, insatiably. His skin itched so badly, it became difficult to put on clothes, shower, sleep and go to work. He eventually needed sleep medication so he could get uninterrupted rest.

Even then, he itched subconsciously, only realizing what happened when he woke up in the morning to find his arms and sheets covered in blood. Some nights, he tried to sleep on his forearms so his body wouldn't touch the sheets, because his skin grew too sensitive to any touch. At one point, he had more than 30 open wounds on his body.

"It's something that's so pervasive and so destructive that a lot of people have mental problems -- you can't do anything without extreme pain," Eric said. "You bleed a lot through the tumors, through the lesions, through the scratching. A lot of people don't survive, really, because of the mental stress that comes with it."

Doctors had a hard time diagnosing his disease because it is often confused with psoriasis, eczema or other skin conditions. Eventually, they determined he had a rare form of skin cancer called mycosis fungoides, a type of T-cell lymphoma that affects one in 6 million people in the United States and Europe. At the time, Eric Shaw was 38.

In 2013, he and Crystal pushed for a referral to Stanford Cancer Center, which has leading experts in the disease. Mycosis fungoides is so rare, it accounts for only 4% of all non-Hodgkin lymphoma cases; among those who suffer from it, only 20% have the type of itching Eric experienced. Rarer still is to find it in people under the age of 40, and African American men often end up with the worst prognosis. All the odds were firmly against him.

"When you first hear skin cancer, your mind doesn't go too far," David said. "So initially I was like, 'There are creams and other minor surgeries. I think it'll be OK.' And then Eric said, 'No, this is not the typical skin cancer. This is inside my body. This is inside the layers of my skin, and it's not one spot. It's everywhere.'

"I didn't really get it for weeks after that because, rectifying something that I didn't think was so serious to [then thinking] ... 'Oh my gosh. So this is really cancer. This is really scary now.' It took a long time for that to sink in."

David turned it over in his mind. He was the big brother, the protector, the one who always made sure Eric would be OK. They were supposed to raise their kids together, grow old together, and reminisce about the randomness of a life spent together.

He kept coming back to one thought: You're not supposed to lose your little brother.

David and Eric Shaw grew particularly close as children as they moved from place to place when their father, Willie, took new coaching jobs. Tawnya, their older sister, fit in anywhere socially. But David and Eric, who is two years younger, stuck together.

"Like a pair," David said.

They loved riding their bikes and, when they moved to Arizona, they took advantage of the wide-open spaces in the new development where they lived. They rode for miles and miles, setting up their own ramps and doing tricks and wheelies, visiting friends along the way before returning home after dark. They played sports, too, and though David loved football as much as their dad, the basketball court is where the brothers had their epic battles.

"I was always kind of a little bit stronger and I'll never forget the last time we played one-on-one basketball," David said. "He just got better than me, and he won, and once I got over the anger and disappointment, I was proud because my younger brother had grown and was gaining confidence."

Said Eric: "I wanted nothing more than to beat him, and he wanted nothing more than to keep beating me. But, during those times, it was just us, it was me and him. He was my best friend."

David went on to play at Stanford and eventually got into coaching, against his mother's best wishes. Eric did not pursue a career in athletics. He went to San Diego State and got into a career in marketing at a financial services company, where his gregarious nature, big smile and easy laugh made him a perfect fit. Though their personalities are different -- David is stoic and introspective, Eric makes anyone feel as if they have been friends forever -- they are grounded in the same values they learned at a young age: family and faith above everything else.

Those principles only grew stronger after they found themselves in the Bay Area as adults.

After David was hired by Stanford, the entire Shaw family made it clear it would always be around to support him. Family members all have a standing invitation to come for dinner on Tuesdays. And they always attend home football games, waving and hugging David during the team's pregame walk, cheering from the stands, and then waiting for some time together once the game ends.

Even as Eric grew sick, he made it a point to go cheer for his big brother. "It's not just the football game. Our family comes together," he said. "We celebrate, we come to watch the game and cheer the team on and support David. And then afterwards, win or lose, we all wait for him to come out. It's a family day. It's been wonderful to share that experience with David."

Stanford eventually drew them even closer, and it had nothing to do with football.

Eric did not understand the gravity of his situation until his first meeting in 2013 with the doctors at Stanford Cancer Center. They put it bluntly: He had such an aggressive form of the disease that he needed immediate treatment. They would start with total skin radiation, preparing Eric to lose his hair, eyebrows, eyelashes, fingernails and toenails.

If that did not work, they would try chemotherapy next.

"All these thoughts are running through your mind," Crystal said. "'Is he going to make it? Is it going to work? What's going to happen?' At the time, our youngest daughter was 3 months old, so it was pretty overwhelming. We were just putting our lives together and then boom: you're in the middle of this cancer war."

The next week, Eric took a leave of absence from work and began four-times-a-week trips from their home east of Palo Alto, California, to Stanford Hospital, often driving as many as three hours one way in traffic. When he arrived, he went into a box and his whole body was exposed to the radiation light for about an hour. Then, he would make the drive back home to see Crystal and their four kids -- Caleb Michael, Jared Spann-Shaw, Madison Shaw and Olivia Shaw.

The radiation charred his skin. He lost weight. When he looked in the mirror, Eric no longer recognized the man looking back at him.

"Nothing prepares you for something like this," he said. "Knowing that other people were looking at me and knowing that something was very wrong, that was a daily grind to get myself up out of bed and get ready for the day, knowing that that was going to be my life."

He did this for three straight months, all to keep the disease from growing to a point where it would kill him. It worked for a short time, but the disease came back more aggressively six months later. Doctors moved on to chemotherapy treatments, some of them experimental, but also began discussing the last-resort option: a bone marrow transplant.

David and Tawnya immediately volunteered to become donors, and underwent testing. In most cases, siblings are the best chance at a donor match. Unfortunately, in their case, neither was close. On a 10-point match scale, Tawnya registered a 3, David a 5. Neither qualified to donate.

"I wanted to jump to the front of the line and say, 'Whatever I have to do, whatever you have to take out of me, however you have to do it, just do it,'" David said. "For them to come back and say that you're not a strong enough match was disheartening. It hurt me. The fact that we had to put our trust and faith in people that we didn't know, and that we're going to have to go out to registries and try to find someone who was a better match than I was, that uncertainty, and that doubt, it's hard to keep it at bay at that point. It starts to creep in."

In late 2017, the disease came back so strong, doctors determined Eric needed the long-discussed bone marrow transplant. Finding a suitable match was exceedingly difficult: Only 4% of donors on the bone marrow registry are African American, resulting in only a 16% chance to find a match.

Doctors eventually found two donors whom they believed could work, but they were not perfect matches. In early 2018, Eric and his family moved into a two-bedroom apartment near Stanford Hospital to prepare for the transplant. For three months, he went through radiation, then chemotherapy to prepare his body to accept the donor cells.

He underwent the transplant in April, feeling confident and inspired it would work. After a month, doctors did an initial check to see how many of the donor cells had survived the transplant.

None survived.

"It was like I never even had the transplant," Eric said. "That was so devastating. We just knew it was going to work. I mean, we're people of faith, and we knew everybody was praying for us, and that we were praying that this six-year journey was going to finally be over. And it wasn't over. It was crushing for them to say, 'It didn't work. We're going to have to try again.'"

The second attempt happened in September. Crystal bought lime green pins for the family to wear for lymphoma awareness. Without telling Eric or Crystal, David decided he would wear his on his shirt for the 2018 football season. In addition to that, he had lime green and yellow ribbons placed on the back of Stanford helmets as a way to show support for both cancer patients and cancer survivors.

He told his team that his brother was fighting cancer, and briefly mentioned the helmet ribbons publicly during an early-season news conference. But beyond that, David kept the severity of what was happening to his brother to himself, masking his growing nervousness, fear and anxiety as the clock ticked toward the next transplant. He had a hard time processing what was happening. He did not want to put that at the feet of his players, or his staff.

The doctors used the same donor cells that failed the first time for the second transplant on Sept. 11, 2018, because that was the only option available. But this time, doctors used even stronger drugs to prepare Eric's body to receive the donor cells -- hoping that would do enough to stop his immune system from attacking them.

When Stanford played Oregon on Sept. 22, no one in the Shaw family knew whether the transplant had worked. But the situation was more dire than the first transplant. The stronger chemotherapy caused major complications, and Eric became severely ill.

David coached the game with this in the back of his mind. Stanford rallied from a 21-7 deficit to win an overtime thriller, moving to 4-0 on the season, with a top-10 matchup against Notre Dame the following week. Back in Palo Alto, Eric watched the entire game alone in an apartment he rented near the hospital, the comeback buoying his spirits.

He had no idea his brother would speak to him through the television until he heard the words, "To my brother Eric ..."

"In that moment, I didn't feel any sickness at all," Eric said. "I can't really describe what I felt, just how proud I am of him and how awesome it made me feel that he would do that for me."

Said David: "If that transplant didn't work, I didn't know how many more games he was going to be able to see. That was an opportunity for me on national TV to speak to him, to say to my brother that against the odds, we came back and throughout the entire game, I was thinking about him."

Eric soon returned to Stanford Hospital. The chemotherapy destroyed his blood system, so he needed daily blood transfusions to stay alive. It came as no surprise when doctors told him the second transplant had failed. They had no plan now, no other donor options. David came by to visit as often as he could, but he had a hard time finding the words to say to his dying brother.

"I thought about Crystal. I thought about their kids," Shaw said. "I thought about, 'How can we help?' And then I kept going, 'We just can't get there. There has to be something else.' And we all prayed and we all comforted each other and trusted the doctors and prayed for the doctors. And just kept saying, 'Just tell us whatever options there are. Just tell us what to do and we'll do it.'"

During the day, Eric had his mother, Crystal, David, or David's wife, Kori, at his side, helping to keep his mind off what was happening to him. But in the evenings, when he was alone in his hospital room, he couldn't help but think about the dwindling medical options and his own death, slowly accepting what he believed would inevitably come.

Over seven years, everything the doctors tried had failed, and the disease always came back more aggressively. He felt exhausted in every possible way, desperate to feel better. He didn't want to die. All he wanted to do was get better, and see his kids again, hug his wife and go home. But that possibility seemed as far off as the stars.

"The doctors couldn't help us," Eric said. "They had lost all hope. There was nothing left, but we were in the deepest part of the valley, and there was nobody there but God. I said, 'You're going to take me off this Earth.' And he told me, 'Eric, you're not going to die.' That was the point at which my faith really took over, and I really had true peace."

His team of doctors huddled together again and came up with a plan many of their colleagues questioned, simply because they had never attempted it. In mid-October of 2018, they told Eric they wanted to try a third transplant.

Only this time, they wanted David to be the donor and they had only weeks to make it happen.

Eric thought, "Are they trying to kill me?"

When David was initially rejected, doctors had worked for 25 years to find a way to do half-match transplants but had virtually no success. By 2018, doctors explained that a different way to do the transplant had emerged, opening up the potential to try it with Eric. These transplants, called haploidentical transplants, typically use donor cells from a family member.

Dr. Wen-Kai Weng, Eric's bone marrow transplant physician, explained, "It was relatively new at this time. We decided to go ahead, because we knew if we didn't do it, the disease would really come back with a vengeance."

No one had ever done a third transplant with donor cells at Stanford.

"If he didn't go for this risk, he wouldn't be here," said Dr. Youn Kim, who treated Eric and heads Stanford's multidisciplinary Cutaneous Lymphoma Clinic/Program. "He wouldn't be living."

Doctors told Shaw there was a 15% chance he would not survive the transplant itself. If he did survive it, there was only about a 30% to 40% chance the donor cells would work. Compared to much steeper survival odds with no transplant at all, the decision -- filled with multiple layers of danger -- did not feel risky at all.

They had to try.

"They might have told us what the odds were, and I honestly just pushed it out of my brain," David said. "If this is the Hail Mary, hey, we're going to drop back and throw it as far as we can and send prayers along with it and hope that it works."

Without hesitation, David said to his brother, "Tell me what I need to do."

Stanford gathered in its team hotel early on Oct. 27 to begin final preparations before hosting Washington State later that day. David checked in for a 9 a.m. meeting and when it finished, he checked out of the hotel without saying a word. He walked toward the back exit, careful to make sure no one saw him, and snuck out the door to a waiting car.

Shaw sat in the passenger seat, headed toward campus and Stanford Hospital, praying all the while that what he was about to do would work.

He arrived at the hospital and was hooked up to an IV for the first dose of medication. This would not be the more traditional bone marrow transplant, where cells are extracted with a needle through the hips. Rather, the medication flowing through the IV would stimulate his body to overproduce the stem cells needed for the transplant, flooding his blood with them. The cells would then be extracted from his blood, and transplanted into Eric.

Doctors told him to expect to start feeling joint pain and tiredness within 24 hours. Those symptoms would grow only stronger over the coming days, when he came in for more medication. They told him he should stay off his feet, rest and remain hydrated.

That would be nice, David thought. But he had a game to coach. Only two people inside the program knew he had gone that morning: assistant athletic director for football operations Callie Dale, who drove him to the hospital, and defensive coordinator Lance Anderson.

"The way that I do my job, I work really hard not to make it about me," David said. "Although I wanted my team to know what my family was going through, college football is about the student-athletes. I wanted them to focus on what they needed to do. I didn't want to pull from that. I didn't want to, all of a sudden, now make it about me and my family."

A few hours later, he returned to the team hotel and acted as if he had been there the entire day, speaking nothing about his trip to the hospital. Shaw put on his lime green pin and made his way toward the bus. The short ride to the stadium felt long that day. His mind wandered before returning to the flip card in front of him.

As he exited the bus and finished the walk to the stadium, his two young nieces ran up to him. They squeezed him, holding on longer than usual, as if they knew their Uncle David was their only option, too.

David started to feel pain in his knees and legs during the game, a heartbreaking 41-38 loss to the Cougars. That pain only intensified in the coming days as he continued to go in for daily treatments, driving himself on a golf cart from the football facility to the hospital without anyone knowing. It felt as if he had a 50-pound backpack strapped on at all times. He normally jogs from place to place during practice but found it difficult to walk because his legs, hips and shoulders hurt so badly.

He worried players would notice him moving around so slowly. If they did, no one said a word. Shaw kept pushing the pain aside, shoving his emotions down deep, saying prayers every chance he got.

On Wednesday, Shaw woke up and was so lethargic, he felt as if he was moving like a sloth. He went to the hospital for the final procedure: extracting the cells from his blood. Shaw wore comfortable clothes, arranged his pillows and settled in for a long day ahead. Doctors hooked him up to a machine that would do the work through two IVs: One took his blood so the needed donor cells could be siphoned out; the other IV would put the blood back in his body.

Eric rested on another floor in the same hospital.

David worked on his game plan, watched a few movies and occasionally stared at his own blood in the IVs, willing it to save his brother. He kept saying to himself over and over again, "God, I hope this works."

After eight hours, he was finished. Shaw then went out to practice.

"I remember walking up to him and just asking him, 'How are you doing, how are you feeling?'" Anderson said. "I could see it in him that he wasn't his normal self. He paused for a little bit and then he's like, 'I'm OK. A little bit tired, but I'm OK.' You know, just trying to put the most positive light that he could on it."

The next day, Nov. 1, 2018, Shaw went back to the hospital. It was transplant day, and he had to be with Eric to witness what they hoped would be a miracle. David and Crystal watched as Eric received a transfusion of David's stem cells, a shimmering light pink fluid flowing into his body. They sang and prayed. Already, they had received one small bit of good news: Doctors extracted 28 million cells from David's blood, about 20 million more than what they had hoped to get.

Stanford traveled the following day to Seattle, for a game against Washington. David felt guilty for leaving, but he knew there was nothing else he could do. Eric struggled in the hospital, not only from the transplant, but from the heavy chemo and radiation doctors used to prepare his body for the new cells.

Eric ran a fever of 105 degrees and vomited for days. The pain grew so intense he was put on a morphine drip and was in and out of consciousness. In Seattle, Shaw remembers being locked into the game, "except for those little moments where my heart was with my brother."

Stanford lost another heartbreaker, 27-23.

"I know us losing had nothing to do with everything David was going through," Dale said. "But just piling that on with everything else he was dealing with, it was a lot for him. He brought that up many times, about how Eric would tell him the biggest excitement for him every week was watching us play and watching us win. I know David had a lot of pressure on himself, amongst the pressure he already has as a head coach, to win for Eric. And I know that every time he did, he really felt like it was for him. And when we came up short, I know he was probably even harder on himself than he normally would have been."

Back at Stanford, David visited Eric when he could. But the waiting game took an increasing mental toll. David prides himself on his ability to compartmentalize, to focus on the only thing in front of him. He never spaces out, and he rarely gets emotional. But Shaw was falling apart on the inside.

He often found himself staring at cut-ups of red zone plays, not realizing the film had been paused for 20 minutes while his mind drifted off. Whenever that happened, he would stop and call someone, either his brother, his wife, his mother or Crystal just to see how they were doing.

"There were times where I thought life was slow motion, but it was actually moving and I was the one who was in slow motion," David said. "I found myself sometimes saying, 'Is this real? Is this really happening? This shouldn't happen.'"

In the middle of every single meeting, in the middle of every single film session, he silently prayed, "God help my brother. Just please let this one work."

"I look back now and I know more of everything that was going on and the situation," Anderson said. "I realized how much he was dealing with and how much he had to bear that week. And it's amazing that he was able to go through that week without really letting any of us really know exactly what he was going through and what a big deal this really was."

Within a few weeks, Eric started to turn a corner. Though they did not know whether the transplant had worked just yet, he showed enough improvement to leave the hospital after 52 days. David arrived for the big day, and Eric slowly put on a protective mask before shuffling to a waiting wheelchair. Doctors, nurses and support staff lined the hallway, clapping and cheering.

David cries when recalling that moment, his pent-up emotions flooding out as he describes it publicly for the first time.

"This is my little brother, after years of cancer, getting to leave the hospital," Shaw said, his voice quavering. He pauses to wipe tears from his eyes. "The nurses were crying. The doctors were crying. Because a few months earlier, they were preparing us for him to die. And he got to go home."

Three days later, doctors met with Eric and Crystal to deliver the results from the transplant. After only 27 days, Eric had none of his own blood coursing through his body.

It was all David's.

Eric picked up the phone.

"Dave," Eric said. "You have a twin. We're truly blood brothers."

See the article here:
'We're truly blood brothers' - Stanford coach David Shaw and his recent fight to save his brother, Eric - ESPN

‘We’re really blood brothers’ – Stanford coach David Shaw and his current battle to save lots of his brother, Eric – The Shepherd of the Hills Gazette

David Shaw walks into the hospital room and takes a seat next to the bed. He does this nearly every day, right around lunchtime.

He looks at his younger brother, Eric, tubes snaking across his arms, machines beeping and whirring. Eric does not look like Eric anymore, his skin darkened, scars deepened, features altered. They both know this but never mention it.

They talk about movies, or random memories from their childhood when they were often inseparable, riding bikes, playing video games and challenging each other to one-on-one basketball. They avoid talking about why David comes as often as he does to visit, though they know the reason.

Eric is dying, a rare, aggressive skin cancer rampaging through his body with such ferocity that his doctors are nearly out of options. Radiation failed. Chemotherapy failed. Two bone marrow transplants failed.

As Stanfords head football coach, David Shaw is relied on to always know what to say, how to say it and when to say it; but he cannot find the words now that he and his brother are staring down what seems to be an inevitable fate.

David Shaw and the Stanford Cardinal open their pandemic-delayed season Saturday, when they travel to face Pac-12 rival Oregon.John Todd/isiphotos.com

What do you say, where you think youve pulled at the last thread and there are no more threads? David said. All I could tell him was that I loved him and that I was there for him. The rest of it was really just I thought it was only a matter of time before he passed away.

Two years later, what happened between David and Eric remains real, present and raw changing their entire relationship, redefining what it means to be a brother. The words are still difficult to say, so they tip-toe around the crushing physical and mental toll Erics cancer took on them.

David and Eric are sure to think about it all this weekend, when Stanford opens its season at Oregon on Saturday. Because the last time the Cardinal visited Eugene, neither one knew whether Eric would live or die.

After Stanford came from behind to win that game 38-31 in overtime, David delivered a message at the end of his postgame television interview, looking at the camera and saying, To my brother Eric: I love you. He tapped the lime green pin on his black Stanford sweatshirt before he left the screen.

When Shaw became head coach at Stanford in 2011, it was the culmination of a family journey. His father was a longtime coach there; David played receiver for the Cardinal and eventually returned as an assistant under Jim Harbaugh. The entire Shaw family parents Willie and Gay, along with David, Eric and their sister, Tawnya all call the Bay Area home.

To this day, David says the day he was introduced as coach was one of the better days in all our lives.

Yet something started to happen to Eric that no one could quite figure out. That same year, Eric found strange looking spots on his torso. His wife, Crystal, noticed the first one under his arm. Maybe it was eczema, they thought. Then the spots started to spread. He went to the doctor. They prescribed an ointment, but the spots kept popping up, until they covered his entire body. Eventually, tumors started to grow. It looked as if someone had pushed marbles under his skin. Doctors remained confounded. Eric itched uncontrollably, insatiably. His skin itched so badly, it became difficult to put on clothes, shower, sleep and go to work. He eventually needed sleep medication so he could get uninterrupted rest.

It took several years before Eric Shaws illness was properly diagnosed as a rare form of skin cancer called mycosis fungoides. Early signs were spots all over his body, similar to psoriasis, before tumors began to form underneath his skin.Courtesy Shaw Family

Even then, he itched subconsciously, only realizing what happened when he woke up in the morning to find his arms and sheets covered in blood. Some nights, he tried to sleep on his forearms so his body wouldnt touch the sheets, because his skin grew too sensitive to any touch. At one point, he had more than 30 open wounds on his body.

Its something thats so pervasive and so destructive that a lot of people have mental problems you cant do anything without extreme pain, Eric said. You bleed a lot through the tumors, through the lesions, through the scratching. A lot of people dont survive, really, because of the mental stress that comes with it.

Doctors had a hard time diagnosing his disease because it is often confused with psoriasis, eczema or other skin conditions. Eventually, they determined he had a rare form of skin cancer called mycosis fungoides, a type of T-cell lymphoma that affects one in 6 million people in the United States and Europe. At the time, Eric Shaw was 38.

In 2013, he and Crystal pushed for a referral to Stanford Cancer Center, which has leading experts in the disease. Mycosis fungoides is so rare, it accounts for only 4% of all non-Hodgkin lymphoma cases; among those who suffer from it, only 20% have the type of itching Eric experienced. Rarer still is to find it in people under the age of 40, and African American men often end up with the worst prognosis. All the odds were firmly against him.

When you first hear skin cancer, your mind doesnt go too far, David said. So initially I was like, There are creams and other minor surgeries. I think itll be OK. And then Eric said, No, this is not the typical skin cancer. This is inside my body. This is inside the layers of my skin, and its not one spot. Its everywhere.

I didnt really get it for weeks after that because, rectifying something that I didnt think was so serious to [then thinking] Oh my gosh. So this is really cancer. This is really scary now. It took a long time for that to sink in.

David turned it over in his mind. He was the big brother, the protector, the one who always made sure Eric would be OK. They were supposed to raise their kids together, grow old together, and reminisce about the randomness of a life spent together.

He kept coming back to one thought: Youre not supposed to lose your little brother.

David and Eric Shaw grew particularly close as children as they moved from place to place when their father, Willie, took new coaching jobs. Tawnya, their older sister, fit in anywhere socially. But David and Eric, who is two years younger, stuck together.

Like a pair, David said.

They loved riding their bikes and, when they moved to Arizona, they took advantage of the wide-open spaces in the new development where they lived. They rode for miles and miles, setting up their own ramps and doing tricks and wheelies, visiting friends along the way before returning home after dark. They played sports, too, and though David loved football as much as their dad, the basketball court is where the brothers had their epic battles.

I was always kind of a little bit stronger and Ill never forget the last time we played one-on-one basketball, David said. He just got better than me, and he won, and once I got over the anger and disappointment, I was proud because my younger brother had grown and was gaining confidence.

Although they have different personalities, brothers David, left, and Eric Shaw formed a strong bond as children. They were like a pair, David said.Courtesy Shaw Family

Said Eric: I wanted nothing more than to beat him, and he wanted nothing more than to keep beating me. But, during those times, it was just us, it was me and him. He was my best friend.

David went on to play at Stanford and eventually got into coaching, against his mothers best wishes. Eric did not pursue a career in athletics. He went to San Diego State and got into a career in marketing at a financial services company, where his gregarious nature, big smile and easy laugh made him a perfect fit. Though their personalities are different David is stoic and introspective, Eric makes anyone feel as if they have been friends forever they are grounded in the same values they learned at a young age: family and faith above everything else.

Those principles only grew stronger after they found themselves in the Bay Area as adults.

After David was hired by Stanford, the entire Shaw family made it clear it would always be around to support him. Family members all have a standing invitation to come for dinner on Tuesdays. And they always attend home football games, waving and hugging David during the teams pregame walk, cheering from the stands, and then waiting for some time together once the game ends.

Even as Eric grew sick, he made it a point to go cheer for his big brother. Its not just the football game. Our family comes together, he said. We celebrate, we come to watch the game and cheer the team on and support David. And then afterwards, win or lose, we all wait for him to come out. Its a family day. Its been wonderful to share that experience with David.

Stanford eventually drew them even closer, and it had nothing to do with football.

Eric did not understand the gravity of his situation until his first meeting in 2013 with the doctors at Stanford Cancer Center. They put it bluntly: He had such an aggressive form of the disease that he needed immediate treatment. They would start with total skin radiation, preparing Eric to lose his hair, eyebrows, eyelashes, fingernails and toenails.

If that did not work, they would try chemotherapy next.

All these thoughts are running through your mind, Crystal said. Is he going to make it? Is it going to work? Whats going to happen? At the time, our youngest daughter was 3 months old, so it was pretty overwhelming. We were just putting our lives together and then boom: youre in the middle of this cancer war.

David, left, and Eric Shaw back in 2014, roughly around the time Eric started undergoing treatments for a rare, aggressive skin cancer.Courtesy Shaw Family

The next week, Eric took a leave of absence from work and began four-times-a-week trips from their home east of Palo Alto, California, to Stanford Hospital, often driving as many as three hours one way in traffic. When he arrived, he went into a box and his whole body was exposed to the radiation light for about an hour. Then, he would make the drive back home to see Crystal and their four kids Caleb Michael, Jared Spann-Shaw, Madison Shaw and Olivia Shaw.

The radiation charred his skin. He lost weight. When he looked in the mirror, Eric no longer recognized the man looking back at him.

Nothing prepares you for something like this, he said. Knowing that other people were looking at me and knowing that something was very wrong, that was a daily grind to get myself up out of bed and get ready for the day, knowing that that was going to be my life.

He did this for three straight months, all to keep the disease from growing to a point where it would kill him. It worked for a short time, but the disease came back more aggressively six months later. Doctors moved on to chemotherapy treatments, some of them experimental, but also began discussing the last-resort option: a bone marrow transplant.

David and Tawnya immediately volunteered to become donors, and underwent testing. In most cases, siblings are the best chance at a donor match. Unfortunately, in their case, neither was close. On a 10-point match scale, Tawnya registered a 3, David a 5. Neither qualified to donate.

I wanted to jump to the front of the line and say, Whatever I have to do, whatever you have to take out of me, however you have to do it, just do it,' David said. For them to come back and say that youre not a strong enough match was disheartening. It hurt me. The fact that we had to put our trust and faith in people that we didnt know, and that were going to have to go out to registries and try to find someone who was a better match than I was, that uncertainty, and that doubt, its hard to keep it at bay at that point. It starts to creep in.

[The doctors] had lost all hope. There was nothing left, but we were in the deepest part of the valley, and there was nobody there but God. I said, Youre going to take me off this Earth. And he told me, Eric, youre not going to die. That was the point at which my faith really took over, and I really had true peace.

Eric Shaw, on the point when he thought he ran out of options to treat his cancer

In late 2017, the disease came back so strong, doctors determined Eric needed the long-discussed bone marrow transplant. Finding a suitable match was exceedingly difficult: Only 4% of donors on the bone marrow registry are African American, resulting in only a 16% chance to find a match.

Doctors eventually found two donors whom they believed could work, but they were not perfect matches. In early 2018, Eric and his family moved into a two-bedroom apartment near Stanford Hospital to prepare for the transplant. For three months, he went through radiation, then chemotherapy to prepare his body to accept the donor cells.

He underwent the transplant in April, feeling confident and inspired it would work. After a month, doctors did an initial check to see how many of the donor cells had survived the transplant.

None survived.

It was like I never even had the transplant, Eric said. That was so devastating. We just knew it was going to work. I mean, were people of faith, and we knew everybody was praying for us, and that we were praying that this six-year journey was going to finally be over. And it wasnt over. It was crushing for them to say, It didnt work. Were going to have to try again.'

The second attempt happened in September. Crystal bought lime green pins for the family to wear for lymphoma awareness. Without telling Eric or Crystal, David decided he would wear his on his shirt for the 2018 football season. In addition to that, he had lime green and yellow ribbons placed on the back of Stanford helmets as a way to show support for both cancer patients and cancer survivors.

During the 2018 football season, coach David Shaw and players donned green ribbons to raise awareness for lymphoma.David Bernal/isiphotos.com

He told his team that his brother was fighting cancer, and briefly mentioned the helmet ribbons publicly during an early-season news conference. But beyond that, David kept the severity of what was happening to his brother to himself, masking his growing nervousness, fear and anxiety as the clock ticked toward the next transplant. He had a hard time processing what was happening. He did not want to put that at the feet of his players, or his staff.

The doctors used the same donor cells that failed the first time for the second transplant on Sept. 11, 2018, because that was the only option available. But this time, doctors used even stronger drugs to prepare Erics body to receive the donor cells hoping that would do enough to stop his immune system from attacking them.

When Stanford played Oregon on Sept. 22, no one in the Shaw family knew whether the transplant had worked. But the situation was more dire than the first transplant. The stronger chemotherapy caused major complications, and Eric became severely ill.

David coached the game with this in the back of his mind. Stanford rallied from a 21-7 deficit to win an overtime thriller, moving to 4-0 on the season, with a top-10 matchup against Notre Dame the following week. Back in Palo Alto, Eric watched the entire game alone in an apartment he rented near the hospital, the comeback buoying his spirits.

He had no idea his brother would speak to him through the television until he heard the words, To my brother Eric

In that moment, I didnt feel any sickness at all, Eric said. I cant really describe what I felt, just how proud I am of him and how awesome it made me feel that he would do that for me.

Said David: If that transplant didnt work, I didnt know how many more games he was going to be able to see. That was an opportunity for me on national TV to speak to him, to say to my brother that against the odds, we came back and throughout the entire game, I was thinking about him.

Eric soon returned to Stanford Hospital. The chemotherapy destroyed his blood system, so he needed daily blood transfusions to stay alive. It came as no surprise when doctors told him the second transplant had failed. They had no plan now, no other donor options. David came by to visit as often as he could, but he had a hard time finding the words to say to his dying brother.

I thought about Crystal. I thought about their kids, Shaw said. I thought about, How can we help? And then I kept going, We just cant get there. There has to be something else. And we all prayed and we all comforted each other and trusted the doctors and prayed for the doctors. And just kept saying, Just tell us whatever options there are. Just tell us what to do and well do it.'

During the day, Eric had his mother, Crystal, David, or Davids wife, Kori, at his side, helping to keep his mind off what was happening to him. But in the evenings, when he was alone in his hospital room, he couldnt help but think about the dwindling medical options and his own death, slowly accepting what he believed would inevitably come.

They might have told us what the odds were, and I honestly just pushed it out of my brain. If this is the Hail Mary, hey, were going to drop back and throw it as far as we can and send prayers along with it and hope it works.

David Shaw on when doctors revisited the idea of him being a donor for his brother

Over seven years, everything the doctors tried had failed, and the disease always came back more aggressively. He felt exhausted in every possible way, desperate to feel better. He didnt want to die. All he wanted to do was get better, and see his kids again, hug his wife and go home. But that possibility seemed as far off as the stars.

The doctors couldnt help us, Eric said. They had lost all hope. There was nothing left, but we were in the deepest part of the valley, and there was nobody there but God. I said, Youre going to take me off this Earth. And he told me, Eric, youre not going to die. That was the point at which my faith really took over, and I really had true peace.

His team of doctors huddled together again and came up with a plan many of their colleagues questioned, simply because they had never attempted it. In mid-October of 2018, they told Eric they wanted to try a third transplant.

Only this time, they wanted David to be the donor and they had only weeks to make it happen.

Eric thought, Are they trying to kill me?

When David was initially rejected, doctors had worked for 25 years to find a way to do half-match transplants but had virtually no success. By 2018, doctors explained that a different way to do the transplant had emerged, opening up the potential to try it with Eric. These transplants, called haploidentical transplants, typically use donor cells from a family member.

Dr. Wen-Kai Weng, Erics bone marrow transplant physician, explained, It was relatively new at this time. We decided to go ahead, because we knew if we didnt do it, the disease would really come back with a vengeance.

No one had ever done a third transplant with donor cells at Stanford.

If he didnt go for this risk, he wouldnt be here, said Dr. Youn Kim, who treated Eric and heads Stanfords multidisciplinary Cutaneous Lymphoma Clinic/Program. He wouldnt be living.

Doctors told Shaw there was a 15% chance he would not survive the transplant itself. If he did survive it, there was only about a 30% to 40% chance the donor cells would work. Compared to much steeper survival odds with no transplant at all, the decision filled with multiple layers of danger did not feel risky at all.

They had to try.

They might have told us what the odds were, and I honestly just pushed it out of my brain, David said. If this is the Hail Mary, hey, were going to drop back and throw it as far as we can and send prayers along with it and hope that it works.

Without hesitation, David said to his brother, Tell me what I need to do.

David Shaw went through an unusual bone marrow transplant procedure to help his brother, Eric. Instead of stem cells being extracted from his hips, he was given medication that stimulated his body to overproduce the cells needed for the transplant.Courtesy Shaw Family

Stanford gathered in its team hotel early on Oct. 27 to begin final preparations before hosting Washington State later that day. David checked in for a 9 a.m. meeting and when it finished, he checked out of the hotel without saying a word. He walked toward the back exit, careful to make sure no one saw him, and snuck out the door to a waiting car.

Shaw sat in the passenger seat, headed toward campus and Stanford Hospital, praying all the while that what he was about to do would work.

He arrived at the hospital and was hooked up to an IV for the first dose of medication. This would not be the more traditional bone marrow transplant, where cells are extracted with a needle through the hips. Rather, the medication flowing through the IV would stimulate his body to overproduce the stem cells needed for the transplant, flooding his blood with them. The cells would then be extracted from his blood, and transplanted into Eric.

Doctors told him to expect to start feeling joint pain and tiredness within 24 hours. Those symptoms would grow only stronger over the coming days, when he came in for more medication. They told him he should stay off his feet, rest and remain hydrated.

That would be nice, David thought. But he had a game to coach. Only two people inside the program knew he had gone that morning: assistant athletic director for football operations Callie Dale, who drove him to the hospital, and defensive coordinator Lance Anderson.

On the same day he underwent a bone marrow transplant for his brother, David Shaw received a surprise pregame hug from his two young nieces, Olivia and Madison.John P. Lozano/isiphotos.com

The way that I do my job, I work really hard not to make it about me, David said. Although I wanted my team to know what my family was going through, college football is about the student-athletes. I wanted them to focus on what they needed to do. I didnt want to pull from that. I didnt want to, all of a sudden, now make it about me and my family.

A few hours later, he returned to the team hotel and acted as if he had been there the entire day, speaking nothing about his trip to the hospital. Shaw put on his lime green pin and made his way toward the bus. The short ride to the stadium felt long that day. His mind wandered before returning to the flip card in front of him.

As he exited the bus and finished the walk to the stadium, his two young nieces ran up to him. They squeezed him, holding on longer than usual, as if they knew their Uncle David was their only option, too.

David started to feel pain in his knees and legs during the game, a heartbreaking 41-38 loss to the Cougars. That pain only intensified in the coming days as he continued to go in for daily treatments, driving himself on a golf cart from the football facility to the hospital without anyone knowing. It felt as if he had a 50-pound backpack strapped on at all times. He normally jogs from place to place during practice but found it difficult to walk because his legs, hips and shoulders hurt so badly.

He worried players would notice him moving around so slowly. If they did, no one said a word. Shaw kept pushing the pain aside, shoving his emotions down deep, saying prayers every chance he got.

On Wednesday, Shaw woke up and was so lethargic, he felt as if he was moving like a sloth. He went to the hospital for the final procedure: extracting the cells from his blood. Shaw wore comfortable clothes, arranged his pillows and settled in for a long day ahead. Doctors hooked him up to a machine that would do the work through two IVs: One took his blood so the needed donor cells could be siphoned out; the other IV would put the blood back in his body.

Eric rested on another floor in the same hospital.

David worked on his game plan, watched a few movies and occasionally stared at his own blood in the IVs, willing it to save his brother. He kept saying to himself over and over again, God, I hope this works.

After eight hours, he was finished. Shaw then went out to practice.

I remember walking up to him and just asking him, How are you doing, how are you feeling?' Anderson said. I could see it in him that he wasnt his normal self. He paused for a little bit and then hes like, Im OK. A little bit tired, but Im OK. You know, just trying to put the most positive light that he could on it.

The next day, Nov. 1, 2018, Shaw went back to the hospital. It was transplant day, and he had to be with Eric to witness what they hoped would be a miracle. David and Crystal watched as Eric received a transfusion of Davids stem cells, a shimmering light pink fluid flowing into his body. They sang and prayed. Already, they had received one small bit of good news: Doctors extracted 28 million cells from Davids blood, about 20 million more than what they had hoped to get.

Stanford traveled the following day to Seattle, for a game against Washington. David felt guilty for leaving, but he knew there was nothing else he could do. Eric struggled in the hospital, not only from the transplant, but from the heavy chemo and radiation doctors used to prepare his body for the new cells.

Eric Shaw endured a dangerously high fever, pain and vomiting in the initial days after his third transplant attempt, using his brother Davids cells. A few weeks later, Eric started to turn a corner for the better.Courtesy Shaw Family

Eric ran a fever of 105 degrees and vomited for days. The pain grew so intense he was put on a morphine drip and was in and out of consciousness. In Seattle, Shaw remembers being locked into the game, except for those little moments where my heart was with my brother.

Stanford lost another heartbreaker, 27-23.

I know us losing had nothing to do with everything David was going through, Dale said. But just piling that on with everything else he was dealing with, it was a lot for him. He brought that up many times, about how Eric would tell him the biggest excitement for him every week was watching us play and watching us win. I know David had a lot of pressure on himself, amongst the pressure he already has as a head coach, to win for Eric. And I know that every time he did, he really felt like it was for him. And when we came up short, I know he was probably even harder on himself than he normally would have been.

Read the original:
'We're really blood brothers' - Stanford coach David Shaw and his current battle to save lots of his brother, Eric - The Shepherd of the Hills Gazette

Mark Drought: Are we on the brink of another civil war? – The Advocate

Illustration for election 2020 column

Illustration for election 2020 column

Photo: M. Ryder / M. Ryder

Illustration for election 2020 column

Illustration for election 2020 column

Mark Drought: Are we on the brink of another civil war?

This was written during the run-up to Election Day. Its possible we will have chosen a president by the time you read it, but it could remain unsettled well into December. Some are calling this the most important election in American history. That might be hyperbole; however, it is likely to be the most critical vote since Lincolns reelection in 1864.

Coming at the end of a year in which governmental incompetence may contribute to a quarter-million deaths, this election is more tense than usual. Many of us are voting angrily this time, because of whats been taken from us during the past four years, and what could be lost during the next four. For some, belief in their country has rapidly eroded, as events have transpired that they had never imagined possible.

It started when the GOP toyed with the idea of a game show host as its standard bearer. A majority of the Americans who consider themselves righteous and on the Right decided Trump had the right stuff to lead the free world. This possibility seemed far-fetched, until it began happening. I never thought the Republicans would nominate the worst human being since George Wallace to run for the White House, nor did I think the most vulgar, dishonest, unqualified and unfit candidate in recent memory would receive a minority of votes sufficiently large to put him in the Oval Office.

Four years later, the country has changed in ways wed never have predicted. Candidate Trump promised to drain the swamp, which now smells worse than ever, and would have been a sewer into the prison system, had the Justice Department not joined the executive branch in this cesspool. Yet they tell us not to trust the deep state the functioning part of the government (e.g., the CIA, FBI and NSC) that actually gets things done because it doesnt slavishly parrot the policies and fiats of the Dear Leader enough.

This has also been extended to his handpicked lackeys, such as former Attorney General Jeff Sessions, who was fired for being insufficiently ruthless in running the Justice Dept. as Trumps own personal law firm. His intensely obsequious replacement, Bill Barr, has been enough of a boot-licker to keep the boss happy, thus keeping his job.

In the Trump orbit, sycophants are considered both necessary and virtuous. Ted Cruz whose wife Trump called ugly and whose father Trump called complicit in the Kennedy assassination has failed to defend his familys honor; instead, hes become one of The Donalds more craven lapdogs. The GOPs labeling of liberals as snowflakes seems ironic at a time when the spineless Cruz and gelatinous Lindsey Graham typify Trump Republicans. GOP mavericks such as John McCain are as extinct as the Stegosaurus.

Speaking of snowflakes, did you ever imagine youd see the day a U.S. president would moan that the questions Leslie Stahl asked during a 60 Minutes interview were tougher than those asked of his opponent? Trump looked like he was ready to cry after he fled this unfair interrogation, but we now live in a time when a tough guy who cant face tough questions and calls a free press the enemy of the American people prefers to simply run from both. Its what youd expect from a whiny, fact-averse, habitual liar.

And who would imagine that, in the midst of a 21st century pandemic, Trump Republicans would reject science? We already knew their attitudes toward evolution, stem cell research and climate science, but the scary Trumpian warning that, if elected, Biden would, listen to the scientists, seems as weird as his bizarre accusation that, Doctors get more money if someone dies from COVID.

The Trump era has become a time when you can literally claim anything from birtherism to Obamagate to COVID is a hoax for which hydroxychloroquine is the cure just by saying it. More ominously, Trumpists are undermining our system of governance by claiming the election is rigged and rife with voter fraud, with no evidence whatsoever, just in case they lose.

Meanwhile, they work to restrict peoples ability to vote by sabotaging the postal system and by encouraging armed, thuggish poll watchers to suppress the vote. By the time this election is over, the Orange Mans militias will have diminished Americas faith in free elections, which were once a hallmark of democracy.

The Right threatens a civil war if the election is closely contested. I suspect many of them believe the wrong side won the previous civil war and take exception to the self-evident statement that Black lives matter. Obviously, everyones life should matter, so why do Trump cultists consider Blacks who want to protect their own lives to be anti-American radicals? Could it be because American exceptionalism has become largely about white supremacy, and reflects the views of Klansmen and neo-Nazis, whom our president refers to as some good people?

Walmart has reportedly removed guns and ammo from its shelves due to fears of potential violence brought on by a close election, and some businesses have increased insurance coverage in the face of possible looting. This situation is worsened by the presidents refusal to accept a peaceful transfer of power should he lose. Hes stated that he could lose only if the Democrats cheated, and no prominent GOP leaders oppose his unwillingness to respect the decision of the American people in a free election.

Many Americans have lost respect for their country and their countrymen. Even if Trump loses, nearly half the nation will have voted for a buffoonish bigot responsible for thousands of deaths, whos no friend of democracy or the U.S. electoral system. And should he be reelected, it will be as hard to get his first Trump-Biden debate performance out of my head as it will be to unsee the image of him dancing to the Village Peoples YMCA at his campaign rallies.

Greenwich native Mark Drought (markdrought4@gmail.com) is an editor at a Stamford IT firm and was an adjunct English professor at the University of Connecticut-Stamford.

See the original post:
Mark Drought: Are we on the brink of another civil war? - The Advocate

Brain Development and Disorder Research Receives $1.5 Million NSF Boost – USC Viterbi School of Engineering

Megan McCain, Giorgia Quadrato and Leonardo Morsut have been awarded a four year National Science Foundation grant to develop better organoids, to help us understand human brain development and disease.

A 15-day-old brain organoid: Department of Biomedical Engineering researchers are partnering with Keck School of Medicine of USC to improve the creation of these materials, which can help us better understand brain development and disorders.Image/ Giorgia Quadrato

The human brain is an incredibly complex organ to study in its living tissue form. Researchers cannot experiment on human tissue directly, and animal models are often too different to human physiology to be effective.

For this reason, in the last decade, neurological research has been increasingly turning to brain-on-a-chip organoid models to give researchers living examples to demonstrate brain development, and how to effectively treat brain diseases and disorders. Organoids are grown out of stem cells into new cell clusters that mimic the structure of and features of a whole organ, such as the brain.

Co-principal investigator Megan McCain from the USC Viterbi Department of Biomedical Engineering will partner with fellow co-principal investigators Giorgia Quadrato and Leonardo Morsut in the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC on a four year, $1.5m NSF-funded project to vastly improve the process of developing brain organoids. The project aims to make the end products more consistent and reliable as tools for brain researchers.

McCain is the Chonette Early Career Chair and assistant professor of biomedical engineering at USC Viterbi. She said that one of the biggest hurdles in the current process of organoid creation was their lack of uniformity.

Researchers start with a small group of human stem cells, and then give them some chemical cues to direct their development into brain tissue, but ultimately, the cells are mostly left to their own devices, so they often grow very randomly, McCain said. They divide and differentiate into other cell types in a somewhat haphazard process. So if you make ten organoids, all ten of them will look slightly different.

A brain organoid in a fluidic device from the labs of Megan McCain and Giorgia Quadrato.

McCain said it was this issue that could be detrimental to the accuracy of using organoids in certain types of research, such as the testing of therapeutics and how the brain responds to these drugs, and that organoids needed to be more uniform and reproducible in order to be more effective tools.

Drug testing with organoids today is very challenging because it is hard to separate the effect of the drug from the inherent variability of the organoids themselves, McCain said.

Morsut said that his part of the project involves developing synthetic molecular tools to simplify the analysis of what happens during the formation of brain organoids in a laboratory setting.

The normal molecules that are used by the cells to self-organize, as well as to make decisions, are linked in very complex networks, and we need artificial tools to tease apart the contributions of these different components, Morsut said. The challengeand the exciting partis to use these tools to explain the remarkable phenomenon of self-organization.

McCain said her lab will focus on the device sidethe organ-on-chipand make microfluidic components for growing and studying organoids under more defined conditions.

This will likely improve reproducibility and possibly organoid maturity, which is another major bottleneck, McCain said.

In order to do this, McCains lab will be repurposing a microfluidic device that they previously used to help explanted zebrafish hearts to remain alive longer and regenerate, while also live-imaging the process.

The device, when applied to brain organoids, will constrain the cells in chambers where the team can run experiments through them in a more controlled way, to see if this improves the consistency of the end product.

And we will also be able to image and monitor their reproducibility by putting them in this little device where theyre all growing in the same configuration, McCain said.

Quadrato, an expert in brain organoids, said she was excited about the collaboration, because a multidisciplinary approach was needed to improve the relevance of current organoids.

One way to improve brain organoid-to-organoid reproducibility is to expose them to small molecules to direct differentiation of the stem cells, Quadrato said.

She said that these small molecules unfortunately sometimes have problematic side effects, such as impairing the survival of other non-neural cell types, or skewing tests of potential treatments for brain diseases and disorders.

In our proposal, we suggest an alternative strategy to increase brain organoid reproducibility that does not cause these side effects, and therefore can be used to create organoids to accurately model disease, Quadrato said.

Further information about the project is available from the National Science Foundation.

View post:
Brain Development and Disorder Research Receives $1.5 Million NSF Boost - USC Viterbi School of Engineering

Election 2020: Californias ballot initiative system isnt working. – Vox.com

Finding the best ways to do good.

I live in California. And three weeks before the election, the people in my quarantine bubble sat down in our living room for a nine-hour research project: figuring out how to vote.

Not for our elected representatives or for president, but on kidney dialysis regulations and stem-cell medical research funding and whether to uphold a law passed by the legislature replacing cash bail with a risk assessment system and nine more propositions after those. My ballot was six pages long, many of them on issues Id never thought about before and, after a few frustrating hours figuring out how to vote, will never think about again.

Direct democracy can be a profound and important tool for political change, and 2020 had many examples of that. In several states, voters decriminalized drugs from marijuana to mushrooms sending a powerful message to lawmakers that their constituents are done with the war on drugs. Ive written in past years that voters are way ahead of state legislatures on banning animal cruelty. Americas electoral system definitely benefits from a place for voters to directly weigh in on issues. (My colleague Sigal Samuel has a rundown of the ballot initiatives that we should cheer in todays edition of the Future Perfect newsletter. Subscribe!)

But what it doesnt benefit from is a system like Californias, where ballots get padded out and weighted down with unclearly written ballot propositions on a dozen niche issues. Many people have been frustrated by these problems on their ballots, but California where voters have been asked to simultaneously entertain abolishing and expediting the death penalty, to weigh dueling propositions about plastic bags, to advise the state legislature to overturn US Supreme Court decisions (it cannot do that), and now, on two different occasions, to weigh in on the proper running of dialysis clinics leads the pack.

A system that funnels lots of issues, both big and small, directly to the voters leads to bad policy judgments, because under-informed voters dont have time to research and form opinions on all the issues. It leads to a handicapped legislature that cant do its job, because large sections of state law are untouchable. (In California, for instance, the legislature has to send many propositions to voters because other propositions have prohibited them from legislating directly.) When a voter-approved initiative is unclearly worded, it can cause years of uncertainty because the issue cant easily be sent back to the voters to adjust the wording.

But just because how we run ballot propositions today is a problem doesnt mean we have to give them up altogether. There is a way we can make direct democracy work.

Lets say that you dislike the work your state legislature is doing. In 26 US states and Washington, DC, you have the power to ask voters to pass laws themselves through a ballot initiative.

There are, broadly, three categories of ballot initiatives available in the states that have a citizen initiative process. In the first, citizens draw up a proposed law and put it on the ballot. If other citizens approve it, it becomes a law. In the second, citizens who disapprove of a law the legislature passed put it on the ballot to try to repeal it (called a veto referendum). In the third, citizens propose, and vote on, a change to the state constitution.

Some states only allow some of these types of initiatives, and some dont allow citizen initiatives at all. Maryland and New Mexico, for example, only allow veto referendums; Utah, Wyoming, Washington, Maine, Alaska, and Idaho allow citizens to put forth initiatives, but not constitutional amendments. Illinois, Mississippi, and Florida allow constitutional amendments but not initiatives.

The details of the process to put a new law, a veto referendum, or a constitutional amendment on the ballot varies from state to state, but in general, proponents file their proposed initiative with the state and then start collecting signatures for it. If they collect enough signatures, it goes on the ballot for the next statewide election. If it wins over enough voters at the election, it becomes a law.

Lots of important work has gotten done through ballot initiatives. But in many ways, laws passed via initiative are more problematic than laws passed by the legislature. Because they are not written by professional legislators, they are often unclearly written; many voters report being confused about what ballot initiatives they voted on will do. Many ballot measures are misleadingly structured so that a no vote represents a big, confusing change to the law, while a yes vote does nothing. There is fierce political fighting about initiatives are summarized on the ballot a process that is supposed to be apolitical, but sometimes isnt.

And while initiatives were meant to empower grassroots political movements, the system to put an initiative on the ballot is much easier for large lobbying groups to navigate, and special interest groups drive many initiatives.

In some states, like California, the sheer number of initiatives is starting to get out of hand, which worsens all of the other problems with ballot initiatives, as its easier for voters to see through one misleading proposition than through 10.

Every state does direct democracy in a different way.

But California reliably has one of the longest ballots. In 2016, there were 17 statewide initiatives. The voter guide mailed to all voters to explain them was 224 pages long.

In 2020, the threshold for initiatives to make the ballot was substantially higher (the threshold is set based on turnout in the most recent governors race, and 2018 turnout set records) and there werent as many. But voters still weighed in on bonds to pay for stem cell research, property tax changes, a repeal to the state ban on affirmative action, restoring voting rights for convicted felons, allowing 17-year-olds who will be 18 in November to vote in primaries, more property tax changes, changes to criminal sentencing, allowing rent control in more parts of the state, labor policies for ride-hailing apps, dialysis clinic regulations, a new data privacy law, and abolishing cash bail.

Those were just the statewide initiatives; voters also considered many city and countywide local initiatives. Thats 12 statewide initiatives, more than anywhere else in the country (though Colorado voters came close, with 11.)

California also had by far the most spending aimed at changing minds on ballot initiatives: $708 million in contributions, compared to $121 million in the next most-contested state. Across all 50 states, 120 ballot measures were decided on Election Day.

Californias initiative process permits all three types of resolutions (initiatives to create a new state law, initiatives to veto a state law passed through the legislative process, and initiatives to amend the constitution) and makes it much easier than many states to put an initiative on the ballot requiring just 5 percent of the number of voters who voted in the gubernatorial race in the most recent election to put an initiative on the ballot. Many states require 10 percent of the number of votes cast for governor and many states have competitive elections for governors.

Californias gubernatorial races are almost never competitive and often have very low turnout, which depresses the signature requirement further. In 2016, only 365,880 signatures were needed (in a state with 40 million people and 18 million registered voters) to add an initiative to the ballot. (High 2018 turnout raised the bar somewhat, but as a percentage of total population, its still one of Americas lowest thresholds.)

Finally, its not just easier for laws to make it onto the ballot; its also easier for them to pass. In many states amending the constitution requires a supermajority. In Florida, for example, which amended its constitution this week to raise the minimum wage, a 60 percent majority is required. In California, propositions including those amending the state constitution pass if they get more than 50 percent of the vote.

California was one of the first states that allowed citizen-driven ballot initiatives, and at first, ballot initiatives were sparse. As collecting signatures became easier, the number of California propositions has spiked especially in the last few decades. As a result, the initiative system has grown quite unwieldy and crude in ways that have perverted the initial vision, historian William Deverell at the University of Southern California said this fall.

For all of the drawbacks of ballot initiatives, the variety of different approaches to propositions in different states is a great thing one of the best examples of the state systems function as laboratories of democracy.

We now have some results from those laboratories of democracy, and they suggest that the initiative system works best when there are a manageable number of initiatives on the ballot at election time. Voter participation is higher, and voters are more able to focus their attention on a handful of meaningful, high-value issues: Should we legalize marijuana? Should we reenfranchise people who have been convicted of a crime and served their sentence? Should we change how our state votes?

When voters are snowed under with nearly a dozen propositions, including many on highly specific niche issues like kidney dialysis regulation that theyre unequipped to evaluate, participation drops, and the results become more strongly predicted by which side spent the most money probably because if voters dont have time to look things up, theyre more likely to go with what they saw on TV. The impressive successes of ballot initiatives against the war on drugs this year should have governments in every state thinking about how they can best use ballot initiatives to their full potential.

For the 14 states that dont allow any ballot initiatives, that might mean rethinking that. But for the states that allow ballot initiatives with a very low threshold, and see low participation and high voter confusion as a result, it means rethinking that, too. Promising proposals include raising the signature threshold, capping the number of propositions on the ballot, and restricting counter-propositions conflicting laws on the ballot at the same time.

Direct democracy is a part of our system because of a belief that voters deserve a direct say in how their state is run. The best implementation gives voters a few highly meaningful choices well worth their time. If we cant manage that, were not empowering voters were burdening them.

Sign up for the Future Perfect newsletter. Twice a week, youll get a roundup of ideas and solutions for tackling our biggest challenges: improving public health, decreasing human and animal suffering, easing catastrophic risks, and to put it simply getting better at doing good.

Will you help keep Vox free for all?

Millions of people rely on Vox to understand how the policy decisions made in Washington, from health care to unemployment to housing, could impact their lives. Our work is well-sourced, research-driven, and in-depth. And that kind of work takes resources. Even after the economy recovers, advertising alone will never be enough to support it. If you have already made a contribution to Vox, thank you. If you havent, help us keep our journalism free for everyone by making a financial contribution today, from as little as $3.

Read the original:
Election 2020: Californias ballot initiative system isnt working. - Vox.com

Many Initiatives Still Too Close to Call in California – Courthouse News Service

SACRAMENTO, Calif. (CN) A record 22 million Californians registered to vote ahead of the November general election. While the allure of choosing the next occupant of the White House no doubt spurred many of them to the ballot box, they also had a list of initiatives to decide ranging from whether the state should go to a split-roll property tax scheme to ending the money bail system.

The bid to end cash bail failed, but heres a look at how some of the other propositions are faring even as the vote count continues:

Proposition 15

Ignoring pleas for budget relief from Californias cash-strapped cities and Governor Gavin Newsom, voters are on the verge of rejecting a bid to amend the states landmark tax code and put the squeeze on commercial landlords.

With over 75% of the estimated total vote counted, 52% have voted no on Proposition 15 the so-called split-roll bid. The proponents dreams of raising up to $11.5 billion in new tax revenues for schools and cities is on the ropes, as the measure faces a 426,000 vote-deficit as of Friday.

If the result holds, it would be further proof of the popularity and resiliency of a voter-approved tax scheme that is credited with preventing runaway tax bills for property owners in the Golden State for decades.

Seeking to make taxes more predictable and stable, 63% of Californians voted in 1978 to amend the state constitution in order to slow tax increases for both commercial and residential property. Considered by many as the third rail of California politics, the system caps annual tax increase on both commercial and residential properties.

The tax code has remained largely unchanged despite the fact its long been a target of some of the states most influential labor unions. Former lawmakers and governors even during previous economic downturns have hardly dared to challenge the tax code, wary of its reputation.

But with the state facing a record $54 billion Covid-induced deficit, proponents have been trying to convince voters they could unearth a giant new revenue stream by raising taxes on commercial properties valued above $3 million. The supporters amassed a deep and influential bench featuring Newsom, former Vice President Joe Biden, Facebook CEO Mark Zuckerberg and many of the states largest labor unions.

Leading the fight against the tax reform are a collection of business and agricultural groups, as well as the Howard Jarvis Taxpayers Association named after the author of the original ballot measure. They cast Proposition 15 as the largest property tax increase in California history and claimed it would send commercial rents and the cost of consumer goods skyrocketing.

In the run up to the election, the sides combined to raise a staggering $139 million on Proposition 15.

To pull off a comeback in the coming days or potentially weeks, the proponents are hoping to glean more support from many of the states coastal counties in the final batches of votes.The proposition has had success thus far in counties like Los Angeles (53-47%), San Francisco (71-29%), Santa Clara (56-44%), Alameda (66-34%) and Marin (63-37%).

Proponents can find a glimmer of hope in the fact that according to the Secretary of States latest estimates, there are still nearly 1 million outstanding ballots in Los Angeles and Alameda alone. Statewide, there are an estimated 4.5 million ballots left to be counted as of Thursday evening.

Support fades inland however as voters are rejecting the split-roll scheme in counties like Fresno (40-60%), Tulare (64-36%) Riverside (40-60%) and Sacramento (53-47%). Making the comeback more difficult is the fact the measure is on course for defeat in the major coastal counties of San Diego (44-56%) and Orange (39-61%).

Mary-Beth Moylan, associate dean at University of the Pacifics McGeorge School of Law who also supervises the publication of the universitys California Initiative Review, said the opponents succeeded in hammering home their claim that increased commercial property taxes would eventually trickle down to consumers.

The no side did a good job of saying This isnt a tax that will only be against corporations, its going to impact small businesses, Moylan said.

Proposition 19

California would crack down on longstanding tax breaks for inherited homes but allow older residents the ability to take their cushy property tax rates with them when they move under a closely contested ballot measure.

In a race too close to call as of Friday morning, Proposition 19 was leading by a 51-49% margin.

Backed by Newsom along with realtor and firefighter groups, Proposition 19 is meant to give seniors wishing to move within the state more flexibility. If passed, homeowners over the age of 55 as well as those with certain disabilities and wildfire victims could keep their property tax bill with them if they sell and move to a more expensive place.

Supporters say the change could spur more seniors to downsize or move into retirement centers and carries the bonus of increasing housing supply.

Prop 19 will open up tens of thousands of homes that havent been on the market for decades, creating opportunities for new buyers and helping to stabilize housing costs so more Californians can afford home ownership, the supporters claim on their website.

The proposal, placed on the ballot by the Democrat-controlled Legislature, also purports to raise new revenue for local governments and fire departments, as it would increase the tax hit on in-family property transfers.

Led by the Howard Jarvis Taxpayers Association, the opponents argue the change would punish those simply looking to pass on family homes to their children or grandchildren. They note a similar proposal was nixed by voters in 2018.

This is a billion-dollar tax increase on California families, the taxpayers association warns. The price is too high.

Much like the related split-roll proposal, the residential tax reform proposal has performed well in the San Francisco Bay Area as well San Diego and Ventura counties. But supporters remain on edge as the measure hasnt run up more than 60% support in any county and there isnt a clear result as Proposition 19 is ahead by only 336,000 votes.

Proposition 14

Two decades after greenlighting a taxpayer-funded stem cell research agency, California voters are on the verge of approving billions more to find a cure for chronic diseases and cancers.

Ahead by a 51-49% margin, Proposition 14 would allow the state to sell up to $5.5 billion in bonds to prop the California Institute for Regenerative Medicine and its efforts to fight everything from Parkinsons disease, diabetes, stroke and infectious diseases including Covid-19.

After a ban on federal funding for stem cell research during the George W. Bush administration, researchers in 2004 turned to the state ballot. They ultimately convinced voters by a 59-41% margin to create a constitutional right to study stem cell cures as well as take on $3 billion in new debt.

Since 2004, nearly a dozen states including New York and Maryland have created similar programs but on a much smaller scale.

Now the backers seek to keep the institute afloat with another $5.5 billion infusion that could ultimately cost $7.8 billion to pay off. Supporters include Newsom, the University of California Board of Regents and the American Association for Cancer Research.

Critics countered that private stem cell research has made great strides since 2004 and that the federal funding ban was lifted under President Barack Obama. With the state mired in recession, the editorial boards of several California newspapers concluded it was bad timing for Proposition 14 and urged readers to vote no.

The latest update from the Secretary of State shows over 50% support for Proposition 14 in coastal counties like San Diego, Los Angeles and San Francisco. It has effectively been shut out of the Central Valley and rural counties.

The tight race shows that California voters are cognizant of the states shattered finances and are not overly enthusiastic about inking new bonds during a recession, said Moylan, the UOP professor. She says though the initiative is close, the critics seem to have made a persuasive pitch.

People are not in the mood for bonds; they are concerned about the finances of the state and are not feeling like expenditures or committing money down the line is a great idea, she said.

Like Loading...

Follow this link:
Many Initiatives Still Too Close to Call in California - Courthouse News Service

Doctors Consider Convalescent T Cell Therapy for COVID-19 – The Scientist

Physicians and researchers have had questionable success treating patients with severe COVID-19 with either antibody-based drugs or convalescent plasma. Neither of those strategies is a cell-based therapy, and, in a preprint posted October 26 on bioRxiv,researchers propose collecting SARS-CoV-2specific memory T cells from recovered individuals, banking the cells, and infusing them into patients as a treatment for infections.

There are data now that are coming out from the analysis of the immune response that are suggesting that the T cells are more important for protection than antibodies, says Antonio Bertoletti, who studies the development of immunological therapies at Duke-NUS Medical School in Singapore and did not participate in the work. There is therefore a rationale to use T cells to control the disease, he adds.

Previously, researchers had attempted memory T cell therapy to suppress cytomegalovirus and Epstein Barr virus. The recipients were leukemia patients who received a stem cell transplant to treat their cancer at the same time. It was this success, combined with the T cell findings from COVID-19 patients, that led Antonio Prez-Martnez, a pediatrician at Hospital Infantil Universitario La Paz in Madrid, and his colleagues to consider a cell-based treatment for the coronavirus.

The researchers isolated memory T cells, including some that released interferon gamma, a cytokine necessary for anti-viral immunity, upon exposure to SARS-CoV-2 antigens, from the blood of people who recovered from COVID-19. They showed that it was possible to freeze, store, and thaw these cells and propose that biobanks of memory T cells could be created from convalescent donors to be infused to treat disease. The practice of storing convalescent plasma, which includes antibodies but no immune cells, to treat COVID-19 patients is already in wide use, although with mixed data on its utility.

If you give plasma and antibodies, those antibodies could potentially fight COVID, but they are not produced in that person, so they are just have a normal half-life and they are cleared, says Rory de Vries, an immunologist at Erasmus University Medical Center in the Netherlands who did not participate in the study. But when T cells encounter a virus, they start expanding, and you might actually build your own new immunological memory while youre doing that, which will never happen with plasma.

Despite the theoretical potential, its not an easy approach, de Vries cautions. For one thing, the authors dont only store SARS-CoV-2 specific T cells, they store every memory cell, so that means that you also store your memory for measles or . . . previous vaccinations, he tells The Scientist. And if you infuse these T cells, I dont think we really know what might happen.

In a cell-based treatment, there are also concerns about immunological compatibility of the donor and recipient, just as there would be during an organ transplant, de Vries explains. The authors did characterize memory T cells based on human leukocyte antigens (HLA), molecules responsible for the immune systems ability to distinguish self and non-self. But de Vries cautions that HLA diversity is vast, potentially requiring more extensive characterization than the authors have done in the preprint to make the treatment safe.

According to Prez-Martnez, the HLA matching is sufficient because patients with severe COVID-19 have lymphopenia, a dearth of white blood cells called lymphocytes, a subtype of which are T cells. Lymphopenia is a biological marker of severe COVID-19, he says. The patients who are more lymphopenic have a greater chance of ending up in the ICU and eventually dying.

The lymphopenia triggered by the coronavirus is similar to the lymphopenia induced by chemotherapy drugs in patients before a stem cell transplant, so the transplant wont be rejected, he explains. This lymphopenic window during COVID-19 is the time at which it could be possible to replace a patients missing lymphocytes with SARS-CoV-2-responsive T cells from recovered donors. The idea is that lymphopenic patients dont have enough of their own T cells, so theyre not going to reject donor lymphocytes.

This strategy is complicated and needs some work, says Bertoletti. It could be that for a short time . . . when you are introducing these T cells in a patient, they will be basically able to suppress viral replication and kill the infected cells, he adds, but the unanswered questions of how important HLA matching is and what the appropriate timing for such a treatment complicates matters.

In order to test the safety of the treatment, Prez-Martnez and colleagues are beginning a Phase I clinical trial in patients hospitalized for COVID-19 with lymphopenia. In the transplant setting, doctors have not seen any side effects, he says, so I think that its worth it to try.

C. Ferreras et al., SARS-CoV-2 specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking and large-scale production for Adoptive Cell Therapy,bioRxiv, doi:10.1101/2020.10.23.352294, 2020.

Read more from the original source:
Doctors Consider Convalescent T Cell Therapy for COVID-19 - The Scientist

Canine Stem Cell Therapy Market Analysis, Latest Trends and Regional Growth Forecast by Types and Applications 2020 – TechnoWeekly

The globalCanine Stem Cell Therapy marketwas valued at US$ 118.5 Mn in 2018 and is expected to reach US$ 240.7 Mn in 2026, growing at a CAGR of 9.3% during the forecast period. With COVID-19 pandemic, many industries are transforming rapidly. The Global Canine Stem Cell Therapy Market is one of the major industries undergoing changes. This year many industries have vanished entirely from the market and many industries have risen.

Moreover, the government-backed schemes throughout the globe are offering many advantages to businesses. As the governing bodies are supporting the industries, it is a strong pillar to support the market growth of Canine Stem Cell Therapy in the upcoming decade (2020-2026). Organizations planning to move into new market segments can take the help of market indicators to draw a business plan. With the technological boom, new markets are blossoming across the globe, making it a breeding ground for new businesses.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.alltheresearch.com/sample-request/206

Global Canine Stem Cell Therapy Market 2020: Covering both the industrial and the commercial aspects of the Global Canine Stem Cell Therapy Market, the report encircles several crucial chapters that give the report an extra edge. The Global Canine Stem Cell Therapy Market report deep dives into several parts of the report that plays a crucial role in getting the holistic view of the report. The list of such crucial aspects of the report includes company profile, industry analysis, competitive dashboard, comparative analysis of the key players, regional analysis with further analysis country wise.

Global Canine Stem Cell Therapy Market Analysis by Key Players:

Any questions, Lets discuss with the analyst @ https://www.alltheresearch.com/speak-to-analyst/206

Moreover, one of the uniqueness in the report is that it also covers the country-level analysis of the regulatory scenario, technology penetration, predictive trends, and prescriptive trends. This not only gives the readers of the report the actual real-time insights but also gives country-wise analysis, that plays a vital role in decision making. The inclusion of the report is not limited to the above mention key pointers. The report also emphasizes on the market opportunities, porters five forces, and analysis of the different types of products and application of the Global Canine Stem Cell Therapy Market.

The report splits by major applications:

Then report analyzed by types:

Global Canine Stem Cell Therapy Market Report is a professional and in-depth research report on the worlds major regional market conditions of the Canine Stem Cell Therapy industry, focusing on the main regions and the main countries as Follows:

COVID-19 Impact on Canine Stem Cell Therapy Market:

The outbreak of COVID-19 has brought along a global recession, which has impacted several industries. Along with this impact COVID Pandemic has also generated few new business opportunities for Canine Stem Cell Therapy Market. Overall competitive landscape and market dynamics of Canine Stem Cell Therapy has been disrupted due to this pandemic. All these disruptions and impacts has been analysed quantifiably in this report, which is backed by market trends, events and revenue shift analysis. COVID impact analysis also covers strategic adjustments for Tier 1, 2 and 3 players of Canine Stem Cell Therapy Market.

Get Brief Information on Pre COVID-19 Analysis and Post COVID-19 Opportunities in Canine Stem Cell Therapy Market @ https://www.alltheresearch.com/impactC19-request/206

Table of Contents Includes Major Pointes as follows:

Browse Full Research report along with TOC, Tables & Figures: https://www.alltheresearch.com/report/206/Canine Stem Cell Therapy

About AllTheResearch:

AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realise, that its not just sheer data-points, but the right analysis that creates a difference. While some clients were unhappy with the inconsistencies and inaccuracies of data, others expressed concerns over the experience in dealing with the research-firm. Also, same-data-for-all-business roles was making research redundant. We identified these gaps and built AllTheResearch to raise the standards of research support.

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:

Contact Name: Rohan S.

Email: [emailprotected]

Phone: +1 (407) 768-2028

Read the original here:
Canine Stem Cell Therapy Market Analysis, Latest Trends and Regional Growth Forecast by Types and Applications 2020 - TechnoWeekly

Stem Cell Therapy Market 2020: Size, Professional Survey, and Forecast to 2025 – PRnews Leader

This report on global Stem Cell Therapy market primarily focuses on multi-faceted attributes comprising dynamic untapped market opportunities, end-user profile, vendor landscape, historical and current market status that collectively foster high end growth and sturdy revenue generation with concrete sustenance in global Stem Cell Therapy market. This in-depth research documentation is aimed at unfurling notable development factors and growth propellants that steer growth prospects despite challenging odds and intensified competition.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=PN

To induce a more concrete, real-time synopsis of the current dynamics dominating the global Stem Cell Therapy market, this versatile report attempts to offer a decisive rundown of the major segments comprising of type, application as well as end-user profile, and regional expanse that collectively dominate future growth outlook in global Stem Cell Therapy market.

This future ready report closely monitors and assesses the role of various driving factors and restraints coupled with challenge assessment and elaborate SWOT and PESTEL analysis to arrive at logical deductions. Further in this report, readers are also presented with a 360degree assessment and evaluation of the competition spectrum, emphasizing frontline player activities and investment plans which collectively influence favorable transit in CAGR valuation through the forecast tenure.

Any questions, Lets discuss with the analyst @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=PN

Global Stem Cell Therapy market is segmented based by type, application and region.

Stem Cell Therapy Market segment by Type, the product can be split into

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Stem Cell Therapy Market segment by Application, split into

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

The report is designed specifically to entice reader attention towards identification and analysis of the chief growth propellants as well as dominant restraints and associated forces that optimally trace growth trajectory in global Stem Cell Therapy market.

Besides corrective measures, this intricate research report presentation on global Stem Cell Therapy market as compiled by our inhouse research professionals also features details on CAGR percentage, consumption and production patterns, as well as demand and supply gaps that have been immediate outcome of pandemic emergence and its lingering state.

Besides tracing direct implications of COVID-19 on the aforementioned Stem Cell Therapy industry that have affected production, consumption and overall supplychain, this report also shares critical understanding on the effective evolution scheme likely to elevate manufacturers and stakeholders from debilitating pandemic implications.

To know More Details About Stem Cell Therapy Market research Report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=PN

Further, our team of research professionals have closely followed primary and secondary research methodologies to scout multi-layered information across disparate sources ranging from corporate sources, analytical solution providers, processing institutions to understand and comprehend value chain developments.

This report on global Stem Cell Therapy market primarily focuses on multi-faceted attributes comprising dynamic untapped market opportunities, end-user profile, vendor landscape, historical and current market status that collectively foster high end growth and sturdy revenue generation with concrete sustenance in global Stem Cell Therapy market. This innovative research documentation is aimed at unfurling notable development factors and growth propellants that steer growth prospects despite challenging odds and intensified competition.

Reasons to buy:

* Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

* Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

* Classify potential new clients or partners in the target demographic.

* Develop tactical initiatives by understanding the focus areas of leading companies.

* Plan mergers and acquisitions meritoriously by identifying Top Manufacturer.

* Formulate corrective measures for pipeline projects by understanding Stem Cell Therapy pipeline depth.

* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

* Report will be updated with the latest data and delivered to you within 2-4 working days of order.

* Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

* Create regional and country strategies on the basis of local data and analysis.

Inquire Before Buying Or Ask For Custom Requirement @ https://www.adroitmarketresearch.com/researchreport/purchase/691?utm_source=PN

About Us :

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a Markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable Market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Read the original post:
Stem Cell Therapy Market 2020: Size, Professional Survey, and Forecast to 2025 - PRnews Leader